Intron Biotechnology, Inc.
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
8
Ending by 2030
Oct 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Jan 2 to 18, 2027 · next Jan 2
- 1 fee due Mar 15, 2027The maintenance fee for Kanamycin compound, kanamycin-producing Streptomyces species bacterium, and method of producing kanamycin (US 9,133,492) comes due Mar 15, 2027. Unpaid by Sep 15, 2027, it lapses early.
- 2 fees due Jun 15 to 19, 2027 · next Jun 15
- 1 fee due Aug 25, 2027The maintenance fee for Pasteurella multocida bacteriophage Pas-MUP-1 and use thereof for inhibiting proliferation of Pasteurella multocida (US 10,568,917) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
- 3 fees due Oct 12 to 30, 2027 · next Oct 12
- 1 fee due Nov 10, 2027The maintenance fee for Method for producing biological heme iron, and iron supplementing composition containing the heme iron produced by same (US 9,334,513) comes due Nov 10, 2027. Unpaid by May 10, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D690,828 | Culture media device In force · From the USPTO record | In force | From the USPTO record | |
| US 8,071,352 | Bacteriophage having killing activity specific to Staphylococcus aureus In force · From the USPTO record | In force | From the USPTO record | |
| US 8,232,370 | Antimicrobial protein specific to Staphylococcus aureus In force · From the USPTO record | In force | From the USPTO record | |
| US 8,377,431 | Bacteriophage or lytic protein derived from the bacteriophage which effective for the treatment of Staphylococcus aureus biofilm In force · From the USPTO record | In force | From the USPTO record | |
| US 8,043,613 | Podoviriedae bacteriophage having killing activity specific to Staphylococcus aureus In force · From the USPTO record | In force | From the USPTO record | |
| US 8,951,757 | Method for Selective Labeling of Protein Produced by in Vitro Translation by Using a Marker from Trna Prepared by Using in Vitro Transcription In force · High confidence | In force | High confidence | |
| US 9,133,492 | Kanamycin compound, kanamycin-producing Streptomyces species bacterium, and method of producing kanamycin In force · From the USPTO record | In force | From the USPTO record | |
| US 9,334,513 | Method for producing biological heme iron, and iron supplementing composition containing the heme iron produced by same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,329,165 | Composition for the treatment of ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water In force · From the USPTO record | In force | From the USPTO record | |
| US 8,377,866 | Antimicrobial protein derived from Podoviridae bacteriophage specific to Staphylococcus aureus In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 63: 6 patents in force now held by others · 4 lapsed for an unpaid fee · 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 5 abandoned · 16 no status recorded